Lumos Pharma Inc (LUMO)
4.32
+0.02
(+0.47%)
USD |
NASDAQ |
Nov 14, 12:36
Lumos Pharma Total Assets (Quarterly): 21.36M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 21.36M |
| March 31, 2024 | 28.08M |
| December 31, 2023 | 40.64M |
| September 30, 2023 | 47.75M |
| June 30, 2023 | 56.37M |
| March 31, 2023 | 63.72M |
| December 31, 2022 | 72.29M |
| September 30, 2022 | 79.21M |
| June 30, 2022 | 85.45M |
| March 31, 2022 | 93.19M |
| December 31, 2021 | 100.31M |
| September 30, 2021 | 106.46M |
| June 30, 2021 | 114.27M |
| March 31, 2021 | 120.06M |
| December 31, 2020 | 129.03M |
| September 30, 2020 | 136.19M |
| June 30, 2020 | 172.20M |
| March 31, 2020 | 182.96M |
| December 31, 2019 | 5.526M |
| September 30, 2019 | 106.65M |
| June 30, 2019 | 120.81M |
| March 31, 2019 | 129.27M |
| December 31, 2018 | 130.94M |
| September 30, 2018 | 139.32M |
| June 30, 2018 | 148.01M |
| Date | Value |
|---|---|
| March 31, 2018 | 165.04M |
| December 31, 2017 | 180.70M |
| September 30, 2017 | 139.71M |
| June 30, 2017 | 136.12M |
| March 31, 2017 | 149.62M |
| December 31, 2016 | 174.75M |
| September 30, 2016 | 186.34M |
| June 30, 2016 | 179.45M |
| March 31, 2016 | 199.92M |
| December 31, 2015 | 218.54M |
| September 30, 2015 | 226.82M |
| June 30, 2015 | 243.25M |
| March 31, 2015 | 259.13M |
| December 31, 2014 | 231.22M |
| September 30, 2014 | 85.88M |
| June 30, 2014 | 84.67M |
| March 31, 2014 | 91.74M |
| December 31, 2013 | 70.56M |
| September 30, 2013 | 60.89M |
| June 30, 2013 | 67.01M |
| March 31, 2013 | 71.66M |
| December 31, 2012 | 29.43M |
| September 30, 2012 | 35.01M |
| June 30, 2012 | 39.14M |
| March 31, 2012 | 43.45M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.526M
Minimum
Dec 2019
182.96M
Maximum
Mar 2020
87.11M
Average
85.45M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| Calidi Biotherapeutics Inc | 6.431M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.08M |
| Shareholders Equity (Quarterly) | 10.28M |
| Current Ratio | 4.233 |